Does DROSPIRENONE Cause Product use in unapproved indication? 154 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Product use in unapproved indication have been filed in association with DROSPIRENONE (Angeliq). This represents 4.7% of all adverse event reports for DROSPIRENONE.
154
Reports of Product use in unapproved indication with DROSPIRENONE
4.7%
of all DROSPIRENONE reports
0
Deaths
13
Hospitalizations
How Dangerous Is Product use in unapproved indication From DROSPIRENONE?
Of the 154 reports, 13 (8.4%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DROSPIRENONE. However, 154 reports have been filed with the FAERS database.
What Other Side Effects Does DROSPIRENONE Cause?
Intermenstrual bleeding (1,086)
Amenorrhoea (603)
Heavy menstrual bleeding (436)
Dysmenorrhoea (240)
Intentional dose omission (123)
Nausea (118)
Headache (117)
Menstruation irregular (117)
Product dose omission issue (116)
Wrong technique in product usage process (95)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which DROSPIRENONE Alternatives Have Lower Product use in unapproved indication Risk?
DROSPIRENONE vs DROSPIRENONE\ESTETROL
DROSPIRENONE vs DROSPIRENONE\ESTRADIOL
DROSPIRENONE vs DROSPIRENONE\ETHINYL ESTRADIOL
DROSPIRENONE vs DROSPIRENONE\ETHINYL ESTRADIOL\LEVOMEFOLATE
DROSPIRENONE vs DROTAVERINE